Detalhe da pesquisa
1.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Breast Cancer Res Treat
; 189(2): 455-461, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131830
2.
Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab.
Cardiooncology
; 10(1): 32, 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38812020